Fig. 6From: FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cellsRT-PCR of FOLR1 in each of the different groups (a) (lane M, DL2000 marker; lanes 1-3, rpWPI-FOLR1-SKOV3 group; lane 4, pWPI-SKOV3 group; lane 5, SKOV3 group). Expression of FOLR1 protein in different groups detected by Western blot (b) (lanes 1, rpWPI-FOLR1-SKOV3 group; lane 2, pWPI-SKOV3 group; lane 3, SKOV3 group)Back to article page